The role and utility of faecal markers in inflammatory bowel disease.
about
Fecal calprotectin in inflammatory bowel diseaseHow to predict clinical relapse in inflammatory bowel disease patientsComparisons between myeloperoxidase, lactoferrin, calprotectin and lipocalin-2, as fecal biomarkers of intestinal inflammation in malnourished children.Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel diseaseNeutrophil Extracellular Traps in Ulcerative Colitis: A Proteome Analysis of Intestinal Biopsies.Safety and Efficacy of Granulocyte/Monocyte Apheresis in Steroid-Dependent Active Ulcerative Colitis with Insufficient Response or Intolerance to Immunosuppressants and/or Biologics [the ART Trial]: 12-week Interim Results.Role of high-mobility group box 1 protein in inflammatory bowel disease.Monitoring and detection of disease recurrence after resection for Crohn's disease: the role of non-invasive fecal biomarkers.Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease.Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications.Association of enteric parasitic infections with intestinal inflammation and permeability in asymptomatic infants of São Tomé Island.Competition for Iron Between Host and Pathogen: A Structural Case Study on Helicobacter pylori.Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases.Diagnostic accuracy of fecal calprotectin in assessing the severity of inflammatory bowel disease: From laboratory to clinicFaecal biomarkers for screening small bowel inflammation in patients with Crohn's disease: a prospective study.Accuracy of Faecal Calprotectin and Neutrophil Gelatinase B-associated Lipocalin in Evaluating Subclinical Inflammation in UlceRaTIVE Colitis-the ACERTIVE study.Modified Delphi Process for the Development of Choosing Wisely for Inflammatory Bowel Disease.Detection of calprotectin in inflammatory bowel disease: Fecal and serum levels and immunohistochemical localization.Intergenerational transfer of antibiotic-perturbed microbiota enhances colitis in susceptible mice.Peroxiredoxin 1 expression in active ulcerative colitis mucosa identified by proteome analysis and involvement of thioredoxin based on immunohistochemistry.Increased fecal calprotectin levels in Crohn's disease correlate with elevated serum Th1- and Th17-associated cytokines.Fecal Calprotectin: A Comparison of Two Commercial Enzymoimmunoassays and Study of Fecal Extract Stability at Room Temperature.Unsuspected Small-Bowel Crohn's Disease in Elderly Patients Diagnosed by Video Capsule Endoscopy.Faecal calprotectin level for assessing endoscopic activity and predicting future clinical course in patients with moderately active ulcerative colitis undergoing granulomonocytapheresis: a prospective cohort studyDamage-associated molecular patterns in inflammatory bowel disease: From biomarkers to therapeutic targets
P2860
Q26766527-1ED15EE2-6615-4312-93ED-80BDE10A20F3Q26774575-53E890F5-D885-4BE9-981F-464F1445B8D1Q30275717-E4D36E1C-A5FF-4B0C-BA40-BBD6D1E33432Q33696448-BA2EC1EF-6DB3-4823-9733-6617C5AFF96DQ36155966-FB47E163-34BD-48A1-B3B4-50696F0A6599Q37114622-AAB27AF0-0DFF-42FA-BD3D-81646F12B403Q38528453-787E7E6C-3B6A-4E19-8858-F63ED5B4A4FDQ38657630-2A9479C3-6EB9-424D-8049-3F5226DD9B76Q38742261-009F2EB6-1346-4D91-8A08-D09B4E4C3F90Q38950036-F32451AB-1269-432E-BD8A-C41C394770BAQ39018458-F63D32BD-7644-420D-A690-6A6394D0DEF1Q39028190-BA881842-FC9C-41E9-A3E1-AE2615CE54ECQ39421189-D7024107-74AA-4B1F-81F2-B75EBAD222DCQ41187355-303E7D15-C0F8-49ED-954B-99633E00D4AFQ41407071-ED6E304A-0D32-4554-84AF-B3730E83C1B8Q42499487-2905483B-9E89-4D7D-8A5E-C0D2F6153DD6Q45937561-E223EFDD-AAE2-4821-8CC4-636740C3E4F2Q47134738-23B35F40-D525-4BE6-A852-51E37946659EQ47309165-0A18926B-89A3-414F-AFDB-C6C4BABA78FCQ49513092-0328B8E3-A993-4790-8C72-97C5FB5D8998Q55221315-34325EA1-E94A-4A23-961E-F48B4EFE3E90Q55397418-1749BABE-9EDF-4260-B76B-E9D4EB385489Q55415622-3AE6E393-EA36-4C44-8176-D9B8168D6A3BQ57171631-1CA76EFD-BB4A-4C88-A7B6-49CDD30506ACQ58699651-9374B602-92A2-4A44-8DE7-D9BEC197D4F7
P2860
The role and utility of faecal markers in inflammatory bowel disease.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The role and utility of faecal markers in inflammatory bowel disease.
@ast
The role and utility of faecal markers in inflammatory bowel disease.
@en
The role and utility of faecal markers in inflammatory bowel disease.
@nl
type
label
The role and utility of faecal markers in inflammatory bowel disease.
@ast
The role and utility of faecal markers in inflammatory bowel disease.
@en
The role and utility of faecal markers in inflammatory bowel disease.
@nl
prefLabel
The role and utility of faecal markers in inflammatory bowel disease.
@ast
The role and utility of faecal markers in inflammatory bowel disease.
@en
The role and utility of faecal markers in inflammatory bowel disease.
@nl
P2093
P2860
P356
P1476
The role and utility of faecal markers in inflammatory bowel disease.
@en
P2093
Christoph Beglinger
Emanuel Burri
Frank S Lehmann
P2860
P356
10.1177/1756283X14553384
P577
2015-01-01T00:00:00Z